HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter U Heuschmann Selected Research

Peter U Heuschmann Research Topics

Disease

53Stroke (Strokes)
05/2024 - 05/2003
29Ischemic Stroke
05/2024 - 05/2003
14Atrial Fibrillation
10/2023 - 01/2008
6Heart Failure
07/2022 - 03/2011
5Inflammation (Inflammations)
10/2023 - 01/2015
5Coronary Disease (Coronary Heart Disease)
01/2021 - 10/2007
5Hypertension (High Blood Pressure)
01/2021 - 04/2012
4Breast Neoplasms (Breast Cancer)
10/2023 - 10/2018
4Neoplasms (Cancer)
01/2023 - 10/2018
4Myocardial Infarction
06/2018 - 08/2013
4Deglutition Disorders (Dysphagia)
12/2017 - 01/2015
3Disease Progression
06/2019 - 01/2015
2Infections
03/2024 - 12/2017
2COVID-19
03/2024 - 01/2024
2Vascular Diseases (Vascular Disease)
12/2023 - 07/2022
2Ischemia
11/2023 - 06/2018
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2017
2Diabetes Mellitus
01/2021 - 08/2013
2Atherosclerosis
01/2021 - 05/2011
2Parkinson Disease (Parkinson's Disease)
01/2020 - 01/2019
2Acute Kidney Injury (Acute Renal Failure)
01/2018 - 09/2014
2Pneumonia (Pneumonitis)
12/2017 - 01/2015
2Cardiac Arrhythmias (Arrythmia)
11/2017 - 08/2012
2Cerebral Hemorrhage
10/2017 - 02/2016
2Hemorrhage
02/2016 - 08/2013
2Hyperglycemia
05/2015 - 08/2013
1Fatigue
03/2024
1Chronic Disease (Chronic Diseases)
03/2024
1Autoimmune Diseases of the Nervous System
12/2023
1Reperfusion Injury
11/2023
1Hypoxia (Hypoxemia)
11/2023
1Infarction (Infarctions)
11/2023
1Embolism (Embolus)
10/2023
1Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
06/2023
1Post-Acute COVID-19 Syndrome
06/2023

Drug/Important Bio-Agent (IBA)

13AnticoagulantsIBA
01/2021 - 02/2012
10Vitamin KFDA Link
01/2022 - 10/2012
9Biomarkers (Surrogate Marker)IBA
05/2024 - 08/2013
7N(4)-oleylcytosine arabinosideIBA
01/2022 - 02/2016
5Troponin T (Troponin T1)IBA
12/2022 - 08/2011
4Antihypertensive Agents (Antihypertensives)IBA
01/2019 - 01/2011
4Tissue Plasminogen Activator (Alteplase)FDA Link
01/2015 - 05/2003
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2023 - 11/2019
3AntibodiesIBA
12/2023 - 11/2019
3Immunoglobulin M (IgM)IBA
06/2023 - 11/2019
3TroponinIBA
12/2022 - 08/2011
3danaparoid (Orgaran)FDA Link
01/2020 - 05/2011
3Indicators and Reagents (Reagents)IBA
01/2017 - 10/2006
2Glial Fibrillary Acidic ProteinIBA
02/2024 - 11/2023
2C-Reactive ProteinIBA
10/2023 - 12/2022
2Immunoglobulin A (IgA)IBA
10/2022 - 11/2019
2Immunoglobulin G (IgG)IBA
10/2022 - 11/2019
2salicylhydroxamic acid (SHAM)IBA
01/2020 - 01/2019
2CholesterolIBA
01/2018 - 04/2012
2AlbuminsIBA
01/2017 - 01/2015
2CreatinineIBA
01/2017 - 01/2015
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2015 - 01/2015
2insulin receptor-related receptor (IRR)IBA
01/2015 - 08/2008
2LipidsIBA
04/2012 - 03/2011
2Tobacco Smoke Pollution (Passive Smoking)IBA
12/2007 - 10/2007
1Brain Natriuretic Peptide (Natrecor)FDA Link
05/2024
1pro-brain natriuretic peptide (1-76)IBA
05/2024
1ProcalcitoninIBA
05/2024
1Hydrocortisone (Cortisol)FDA LinkGeneric
05/2024
1Atrial Natriuretic Factor (ANF)IBA
05/2024
1CI 22IBA
03/2024
1Prednisolone (Predate)FDA LinkGeneric
01/2024
1Vitamin B Complex (B Vitamins)IBA
01/2024
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2023
1AutoantibodiesIBA
12/2023
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2023
1Vascular Endothelial Growth Factor BIBA
12/2023
1Complement System Proteins (Complement)IBA
12/2023
1SynucleinsIBA
11/2023
1EndoglinIBA
11/2023
1Fibronectins (Fibronectin)IBA
06/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2023
1Trinitrotoluene (TNT)IBA
12/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
07/2022
1HMGB1 Protein (HMG1)IBA
07/2022
1Adenosine Diphosphate (ADP)IBA
07/2022
1apixabanIBA
01/2022
1SugarsIBA
01/2022
1Triglycerides (Triacylglycerol)IBA
01/2022
1Factor Xa InhibitorsIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1Natriuretic PeptidesIBA
01/2021
12,6-dinitrotoluene (DNT)IBA
01/2021
1Factor XII (Hageman Factor)IBA
12/2020

Therapy/Procedure

13Therapeutics
03/2024 - 05/2003
10Secondary Prevention
01/2021 - 01/2008
5Catheter Ablation
10/2023 - 07/2010
5Length of Stay
10/2017 - 01/2008
5Thrombolytic Therapy
01/2017 - 05/2003
4Thrombectomy
02/2024 - 04/2016
3Aftercare (After-Treatment)
10/2023 - 10/2018
2Deep Brain Stimulation
01/2020 - 01/2019
2Nursing Care
09/2011 - 01/2009
1Adjuvant Chemotherapy
01/2023
1Precision Medicine
01/2023